Joe Nocera

07/21/2014 - 1:30am

    Kalydeco is truly a wonder drug.

    Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s. It doesn't work for every sufferer of the disease but...

07/18/2014 - 1:13pm

    Last week, Standard & Poor's issued a short report about Boeing. "Boeing Co. Faces Long-Term Credit Risks If The U.S. Export-Import Bank Isn't Reauthorized," read the alarming heading.

    In dollar volume, Boeing is America's single largest...

07/14/2014 - 2:46am

    In the same week that a hedge fund, Standard General, essentially took over American Apparel, Bloomberg Businessweek published an eye-opening story about the company and its founder and former chief executive, Dov Charney. Eye-opening not in the usual manner when it comes to Charney: The magazine didn't...

07/10/2014 - 1:53am

    The Andy Raymond rant is a thing to behold.

    Raymond, the co-owner of Engage Armament in Montgomery County, Maryland, is one of the two gun dealers who, a few months ago, tried to sell the Armatix iP1 - aka, the first commercially available "smart gun" - to...

07/03/2014 - 4:31pm

    The title of Kenneth Feinberg's 2012 book is: "Who Gets What: Fair Compensation After Tragedy and Financial Upheaval." It is part memoir and part meditation on some of the well-known compensation systems he has administered during the course of his career, from the Agent Orange settlement to the 9/...

06/26/2014 - 4:44pm

    In the real world, markets aren't perfect.

    If they were, you wouldn't need Fannie Mae to play such a vital role in housing finance. You wouldn't need government to fund research. And you certainly wouldn't rely on an export credit agency to help...

Syndicate content